LRS and Pfizer Inc. to Discuss Windows 7 Migration Challenges

LRS and Pfizer Inc. to Discuss Windows 7 Migration Challenges

SPRINGFIELD, IL – August 20, 2012 –Levi, Ray & Shoup, Inc. (LRS) today announced an upcoming webinar entitled “Output Management in Windows® 7 Deployments.” The one-hour online session will address the printing and document delivery challenges caused by changes in the latest Windows operating system. Registration for the September 7th webinar is available from the LRS website.

Joining LRS will be Todd Bosco, Senior Manager at Pfizer, Inc. Bosco and his team were responsible for developing and deploying Pfizer’s output infrastructure in preparation for their Windows 7 rollout. He will outline the challenges of driver and printer consolidation, explain the benefits of centralized management tools, and answer audience questions relating to their own migration efforts.

To accommodate both European and North America attendees, two live sessions of the webinar are scheduled for Friday, September 7th; the first starting at 10:00am EDT and the second at 3:00pm EDT. Attendees are encouraged to register early and prepare their questions in advance. Additional information is available at: http://www.lrs.com/eom/news/eomseminars/windowswebinar.aspx

About LRS

LRS is a privately-held U.S. company with corporate headquarters located in Springfield, Ill. Remote offices are located throughout the United States and in key geographic regions around the world. More than half of the Fortune 500 and Fortune 500 Service companies rely on industry-leading LRS solutions, with products in use in over 30 countries. Industry analyst groups recognize LRS as a global IT leader and Software Magazine consistently ranks LRS as one of the top software companies in the world. For more information about LRS, visit www.VPSX.com.

# # #

LRS, LRS in the diamond device, and VPSX are registered trademarks of Levi, Ray & Shoup, Inc. All other brand and product names are trademarks or service marks of their respective holders.

« Back to News